Catalent said today that it launched an underwritten public offering for $250 million of its common stock to fund, in part, its $950 million purchase of biologics manufacturer Cook Pharmica. In connection with the offering, Catalent is slated to grant underwriters a 3o-day option to buy up to $37.5 million of additional shares of common stock. Get […]
Funding Roundup
Rennova Health to effect 1:15 reverse stock split
Rennova Health (NSDQ:RNVA) said today that it will effect a 1:15 reverse stock split of its outstanding common stock on Oct. 5. The top level chiropractic care said it expects that the reverse split will help it meet the $1.00 minimum bid price requirement for the Nasdaq market. Based on the number of shares currently outstanding, […]
Lightstone Ventures raises $250m second fund
Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for. Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance […]
Forsight Vision6 drums up another $3m
The sixth company to come out ophthalmology incubator ForSight Labs said today that it raised $3.0 million from a syndicate of nine unnamed investors. Stealthy ForSight Vision6 revealed the equity round in a regulatory filing today. The company added $3.0 million in December 2014 to the $1 million is raised in 20153 from a lone backer. […]
Delcath deal with investors raises $500k, clears path for reverse split
Delcath Systems (NSDQ:DCTH) and a group of investors made an end run around the company’s shareholders with a deal that paves the way for the reverse split that stockowners have twice shot down. “Together with our Board of Directors, we are taking these actions in the best interests of all shareholders. Regaining access to equity capital will […]
Micell raises $62m for MiStent SES
Micell Technologies said last week that it raised a debt-and-equity round worth nearly $62 million from a syndicate of 51 unnamed investors. Paris-based Micell makes the MiStent SES sirolimus-eluting absorbable polymer coronary stent, designed to treat coronary artery disease. The company, which reported a nearly $26 million round last November, said in a regulatory filing that the […]
Velico Medical raises another $19m for Frontline ODP spray-dried plasma
Velico Medical said today that it raised another $19 million for the Frontline ODP spray-dried plasma product it’s developing. Beverly, Mass.-base Velico said the $18.9 million contribution comes from the U.S. Health & Human Services Dept.’s Biomedical Advanced Research & Development Authority. It’s the third option under a contract with Velico that runs through November 2019, […]
Cambridge Medical Robotics raises $26m for Versius robot-assisted surgery device
Cambridge Medical Robotics, fresh from the unveiling of its Versius robot-assisted surgical arm, said today that it added $26 million to the Series A round it plans to use on validation studies and further production. Existing backers Cambridge Innovation Capital, LGT Global Invest, Escala Capital and ABB Technology Ventures were joined by new investor Watrium […]
OrthoPediatrics files for $58m IPO
OrthoPediatrics said this week it filed for an initial public offering, looking to bring in $57.5 million for the company and its pediatric-focused orthopedic device offering. The Warsaw, Ind.-based company said it plans to list on the NASDAQ exchange under the “KIDS” symbol, but has not determined what number of shares will be offered or […]
Rebiotix raises $8.5m for microbiome therapy
Rebiotix has raised $8.5 million in a $10 million offering, according to a regulatory document that the company filed yesterday with the SEC. The offering, which consists of debt and convertible promissory notes, has garnered participation from 29 investors thus far, the company reported. Rebiotix said it is accepting minimum investments of $25,000 and that it doesn’t expect […]
BrainScope raises $16m for TBI assessment device
BrainScope said yesterday that it closed a $16 million funding round for the eponymous traumatic brain injury assessment device it developed. Bethesda, Md.-based BrainScope said new backer DBL Partners joined existing investors Revolution LLC, ZG Ventures, Maryland Venture Fund participated in the round, along with unnamed existing and new investors in the round. “We are delighted to […]